Cargando…

Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine

Readily available peritoneal dialysis (PD) effluents from PD patients in the course of renal replacement therapy are a potentially rich source for molecular markers for predicting clinical outcome, monitoring the therapy, and therapeutic interventions. The complex clinical phenotype of PD patients m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiesenhofer, Florian M., Herzog, Rebecca, Boehm, Michael, Wagner, Anja, Unterwurzacher, Markus, Kasper, David C., Alper, Seth L., Vychytil, Andreas, Aufricht, Christoph, Kratochwill, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348277/ https://www.ncbi.nlm.nih.gov/pubmed/30719009 http://dx.doi.org/10.3389/fphys.2018.01961

Ejemplares similares

Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures
por: Herzog, Rebecca, et al.
Publicado: (2018)

Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid
por: Herzog, Rebecca, et al.
Publicado: (2017)

Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses – A First-In-Man Trial
por: Kratochwill, Klaus, et al.
Publicado: (2016)

Peritoneal Dialysis Fluid Supplementation with Alanyl-Glutamine Attenuates Conventional Dialysis Fluid-Mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses
por: Herzog, Rebecca, et al.
Publicado: (2020)

Vibrational Spectroscopy of Peritoneal Dialysis Effluent for Rapid Assessment of Patient Characteristics
por: Grunert, Tom, et al.
Publicado: (2020)

The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation
por: Boehm, Michael, et al.
Publicado: (2019)

Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Oviedo Flores, Krystell, et al.
Publicado: (2022)

Publisher Correction: Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study
por: Flores, Krystell Oviedo, et al.
Publicado: (2022)

Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
por: Bartosova, Maria, et al.
Publicado: (2020)

Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model
por: Sacnun, Juan Manuel, et al.
Publicado: (2022)

Metabolomic profiling of overnight peritoneal dialysis effluents predicts the peritoneal equilibration test type
por: Kim, Hyo Jin, et al.
Publicado: (2023)

Cross-Omics Comparison of Stress Responses in Mesothelial Cells Exposed to Heat- versus Filter-Sterilized Peritoneal Dialysis Fluids
por: Kratochwill, Klaus, et al.
Publicado: (2015)

Senescence-Associated Changes in Proteome and O-GlcNAcylation Pattern in Human Peritoneal Mesothelial Cells
por: Herzog, Rebecca, et al.
Publicado: (2015)

In-Depth Analysis of the Extracorporeal Proteome Adsorbed to Dialysis Membranes during Hemodialysis
por: Daniel-Fischer, Lisa, et al.
Publicado: (2022)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Peritoneal Effluent Cell-Free DNA Sequencing in Peritoneal Dialysis Patients With and Without Peritonitis
por: Burnham, Philip, et al.
Publicado: (2021)

AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency
por: Corciulo, Simone, et al.
Publicado: (2019)

Transition of lymphocyte subsets in peritoneal dialysis effluent and its relationship to peritoneal damage
por: Ohashi, Atsuki, et al.
Publicado: (2021)

Mesenchymal stroma cells in peritoneal dialysis effluents from patients
por: Liu, Bin, et al.
Publicado: (2017)

Tight junction protein expression from peritoneal dialysis effluent
por: Kim, Sua, et al.
Publicado: (2019)

Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats
por: Karimipour, Mojtaba, et al.
Publicado: (2018)

Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis
por: Zhou, Lan, et al.
Publicado: (2019)

Relation between MicroRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics
por: Chen, Jin, et al.
Publicado: (2012)

Noninfectious Cloudy Peritoneal Effluent in a Peritoneal Dialysis Patient with Mantle Cell Lymphoma
por: Vigil, Darlene, et al.
Publicado: (2018)

Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets
por: Xing, Shen, et al.
Publicado: (2017)

Metabolic engineering of Escherichia coli for efficient production of l-alanyl-l-glutamine
por: Zhu, Jiangming, et al.
Publicado: (2020)

NMR-based metabolomic analysis of the effects of alanyl-glutamine supplementation on C2C12 myoblasts injured by energy deprivation
por: Liu, Zhiqing, et al.
Publicado: (2018)

Peritoneal dialysis effluent-derived exosomal miR-432-5p: an assessment tool for peritoneal dialysis efficacy
por: Tong, Yan, et al.
Publicado: (2022)

Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study
por: Hirahara, Ichiro, et al.
Publicado: (2015)

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis
por: Ossorio, Marta, et al.
Publicado: (2017)

Intervention and Mechanisms of Alanyl-glutamine for Inflammation, Nutrition, and Enteropathy: A Randomized Controlled Trial
por: Moore, Sean R., et al.
Publicado: (2020)

A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis
por: Boehm, Michael, et al.
Publicado: (2019)

Effluent Markers Related to Epithelial Mesenchymal Transition with Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients
por: Mizuiri, Sonoo, et al.
Publicado: (2011)

Seeking Clarity within Cloudy Effluents: Differentiating Fungal from Bacterial Peritonitis in Peritoneal Dialysis Patients
por: Chavada, Ruchir, et al.
Publicado: (2011)

L-alanyl-L-glutamine ingestion maintains performance during a competitive basketball game
por: Hoffman, Jay R, et al.
Publicado: (2012)

Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice
por: Araújo, C.V., et al.
Publicado: (2015)

Glutamine and Alanyl-Glutamine Increase RhoA Expression and Reduce Clostridium difficile Toxin-A-Induced Intestinal Epithelial Cell Damage
por: Santos, Ana A. Q. A., et al.
Publicado: (2013)

Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats
por: da Rosa, Carlos Vinicius D., et al.
Publicado: (2015)

Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers
por: Pearson, Lachlan James, et al.
Publicado: (2017)

Can SARS-CoV-2 be found in the effluent from peritoneal dialysis patients?
por: Candellier, Alexandre, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dt3923jcomehgbljao9u0i6646